Role of the association of high-risk HPV identified by real-time PCR in cervical preneoplastic lesions

European Journal of Gynaecological Oncology

Volumn 33, Issue 5, 2012, Pages 467-471

  Balbi, G ^a   Napolitano, A ^a   Giordano, F ^a   Capuano, S ^a   Manganaro, M A ^a   Di Martino, L ^a   Fusco, D ^a   Grauso, F ^a   Seguino, E ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Endometrial carcinoma; Ichthyosis uteri; Squamous cell carcinoma

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNKNOWN SIGNIFICANCE; CANCER GRADING; CANCER INVASION; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE AMPLIFICATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 60; HUMAN TISSUE; INFECTION RISK; LOW GRADE SQUAMOUS INTRAEPITHELIAL CARCINOMA; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPILLOMAVIRUS INFECTION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS IDENTIFICATION;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; REAL-TIME POLYMERASE CHAIN REACTION; RISK; UTERINE CERVICAL NEOPLASMS;

EID: 84868605926     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Corneanu L.M., Stǎculescu D., Corneanu C., Rom J.: "HPV and cervical squamous intraepithelial lesions: clinico pathological study". Morphol. Embryol., 2011, 52, 89.
2. Chironna M., Neve A., Sallustio A., De Robertis A., Quarto M., Germinario C. et al.: "Frequency of human papillomavirus infection and genotype distribution among women with knowncytological diagnosis in a Southern Italian region. HPV Study Group". J. Prev. Med. Hyg., 2010, 51, 139.
3. Nasser H., Hayek S., Balasubramaniam M., Kuntzman T.J.: "Infectious organisms on papanicolaou smears should not influence the diagnosis of atypical squamous cells of undetermined significance". Acta Cytol., 2011, 55, 251.
4. López M.J., Ili G.C.G., Brebi M.P., García M.P. Capurro V.I., Guzmán G.P., Suárez P.E., Ojeda F.J.M., Roa S.J.C.: "Human papillomavirus genotyping of cervical uterine preneoplastic lesions in a high-risk area". Rev. Med. Chil., 2010, 138, 1343.
5. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L. et al.: "Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia". Vaccine, 2008, 26 (suppl. 10), K1.
6. Trope A., Sjoborg K., Eskild A., Cuschieri K., Eriksen T., Thoresen S. et al.: "Performance of human papillomavirus (HPV) DNA and mRNA testing strategies in women with and without cervical neoplasia". J. Clin. Microbiol., 2009, 47, 2458.
7. Kuramoto H., Sugimoto N., Iida M.: "Screening for cancer of the cervix with simultaneous pap smear and colposcopy. The efficacy of pap smear and colposcopy". Eur. J. Gynaecol. Oncol., 2011, 32, 73.
8. Roberts C.C., Swoyer R., Bryan J.T., Taddeo F.J.: "Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection". J. Clin. Microbiol., 2011, 49, 1899.
9. Carcopino X., Bolger N., Henry M., Mancini J., Boubli L., Olive D. et al.: "Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology". J. Med. Virol., 2011, 83, 637.
10. Pierik A., Zwanenburg C., Moerland E., Broer D., Stapert H., van den Brule A.J.: "Rapid genotyping of human papillomavirus by post-PCR array-based hybridization techniques". J. Ctin. Microbiol., 2011, 49, 1395.
11. Jaberipour M., Samsami A., Sahraiian F., Kazerooni T., Hashemi M., Ghaderi A., Habibagahi M.: "Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer". Asian Pac. J. Cancer Prev., 2011, 12, 163.
12. Stoler M.H., Wright T.C. Jr., Sharma A., Apple R., Gutekunst K., Wright T.L.: "High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study". ATHENA (THE Need for Advanced HPV Diagnostics) HPVStudy Group. Am. J. Clin. Pathol., 2011, 135, 468.
13. Gudleviciene Z., Sepetiene A., Didziapetriene J., Valuckas K.P., Smailyte G., Drasutiene G., Nadisauskiene R.J.: "Prevalence of human papillomavirus types in cervical intraepithelial lesions". Medicina (Kaunas), 2010.
14. Calore E.E., Giaccio C.M., Nadal S.R.: "Prevalence of anal cytological abnormalities in women with positive cervical cytology". Diagn. Cytopathol., 2011, 39, 323.
15. Carter J.S., Sage Y.H., Vragovic O., Rosen L., Stier E.A.: "Effect of patient age on outcomes and compliance in women with minimally abnormal pap tests". J. Reprod. Med., 2010, 55, 35.
16. Muñoz N., Bosch F.X., Castellsagué X., Diaz M., de Sanjose S., Hammouda D. et al.: "Against which human papillomavirus types shall we vaccinate and screen?". Int. J. Cancer, 2004, 111, 278.
17. Um T.H., Lee E.H., Chi H.S., Kim J.W., Hong Y.J., Cha Y.J.: "Comparison of HPV genotyping assays and Hybrid Capture 2 for detection of high-risk HPV in cervical specimens". Ann. Clin. Lab. Sci., 2011, 41, 48.
18. Einstein M.H., Garcia F., Mitchell A.L., Day S.P.: "Age-stratified performance of the cervista(R) HPV 16/18 genotyping test in women with ASC-US cytology". Cancer Epid. Biomark. Prev., 2011, 201, 1185.
19. Chernesky M., Jang D., Portillo E., Smieja M., Chong S., Buracond S. et al.: "Comparative evaluation of AMPLICOR HPV PCR and linear array assays on surepathliquid-based Pap samples for the detection of high-risk HPV genotypes". J. Clin. Virol., 2011, 50, 201.
20. Cuschieri K.S., Cubie H.A., Whitley M.W., Seagar A.L., Arends M.J., Moore C. et al.: "Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population". J. Clin. Pathol., 2004, 57, 68.
21. Trottier H., Mahmud S., Costa M.C., Sobrinho J.P., Duarte-franco E., Rohan T.E. et al.: "Human papillomavirus infection with multiple types and risk of cervical neoplasia". Cancer Epidemiol. Biomarkers Prev., 2006, 15, 1274.
22. Wheeler C.M., Hunt W.C., Schiffman M., Castle P.E.: "Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer". J. Infect. Dis., 2006, 194, 1291.
23. Koshiol J., Lindsay L., Pimenta J.M., Poole C., Jenkins D., Smith J.S.: "Persistent human papillomavirus infection and cervical neoplasia: a systematic review and metaanalysis". Am. J. Epidemiol., 2008, 168, 138.
24. Spinillo A., Dal Bello B., Gardella B., Roccio M., Dacco' M.D., Silini E.M.: "Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions". Gynecol. Oncol., 2009, 113, 115.